1. Home
  2. SIBN vs RAPP Comparison

SIBN vs RAPP Comparison

Compare SIBN & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • RAPP
  • Stock Information
  • Founded
  • SIBN 2008
  • RAPP 2022
  • Country
  • SIBN United States
  • RAPP United States
  • Employees
  • SIBN N/A
  • RAPP N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • RAPP
  • Sector
  • SIBN Health Care
  • RAPP
  • Exchange
  • SIBN Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • SIBN 567.6M
  • RAPP 463.8M
  • IPO Year
  • SIBN 2018
  • RAPP 2024
  • Fundamental
  • Price
  • SIBN $13.85
  • RAPP $10.15
  • Analyst Decision
  • SIBN Strong Buy
  • RAPP Strong Buy
  • Analyst Count
  • SIBN 5
  • RAPP 5
  • Target Price
  • SIBN $24.40
  • RAPP $35.00
  • AVG Volume (30 Days)
  • SIBN 384.6K
  • RAPP 259.3K
  • Earning Date
  • SIBN 05-05-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • SIBN N/A
  • RAPP N/A
  • EPS Growth
  • SIBN N/A
  • RAPP N/A
  • EPS
  • SIBN N/A
  • RAPP N/A
  • Revenue
  • SIBN $167,178,000.00
  • RAPP N/A
  • Revenue This Year
  • SIBN $18.52
  • RAPP N/A
  • Revenue Next Year
  • SIBN $16.39
  • RAPP N/A
  • P/E Ratio
  • SIBN N/A
  • RAPP N/A
  • Revenue Growth
  • SIBN 20.37
  • RAPP N/A
  • 52 Week Low
  • SIBN $11.70
  • RAPP $6.43
  • 52 Week High
  • SIBN $19.16
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 45.88
  • RAPP N/A
  • Support Level
  • SIBN $12.87
  • RAPP N/A
  • Resistance Level
  • SIBN $13.74
  • RAPP N/A
  • Average True Range (ATR)
  • SIBN 0.87
  • RAPP 0.00
  • MACD
  • SIBN 0.08
  • RAPP 0.00
  • Stochastic Oscillator
  • SIBN 69.95
  • RAPP 0.00

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: